Vir Biotechnology, Inc.
Recent Filings
All 748 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 4 | FORM 4 | Mar 24, 2026 |
| 4 | FORM 4 | Mar 23, 2026 |
| 144 | — | Mar 23, 2026 |
| 8-K | 8-K | Mar 4, 2026 |
| SCHEDULE 13D/A | — | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 144 | — | Mar 2, 2026 |
| 8-K | 8-K | Mar 2, 2026 |
| 8-K | 8-K | Feb 26, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| SVF Endurance (Cayman) Ltd | — | Sale | 191,854 @ $5.98 | 13,728,924 | Dec 1, 2025 |
| SATO VICKI L | — | Sale | 22,000 @ $6.00 | 1,188,391 | Dec 1, 2025 |
| SOFTBANK VISION FUND (AIV M1) L.P. | — | Sale | 61,493 @ $6.44 | 13,920,778 | Nov 26, 2025 |
| SVF Endurance (Cayman) Ltd | — | Sale | 235,971 @ $6.38 | 14,110,209 | Nov 24, 2025 |
| O'Byrne Jason | EVP & Chief Financial Officer | Sale | 6,799 @ $5.56 | 110,701 | Nov 17, 2025 |
| de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sale | 2,385 @ $5.16 | 78,210 | Nov 5, 2025 |
| de Verneuil Vanina | EVP and General Counsel | Sale | 1,365 @ $5.86 | 80,595 | Nov 3, 2025 |
| SATO VICKI L | — | Sale | 22,000 @ $5.64 | 1,210,391 | Nov 3, 2025 |
| SVF Endurance (Cayman) Ltd | — | Sale | 24,453 @ $6.50 | 14,574,083 | Oct 29, 2025 |
| SB INVESTMENT ADVISERS (UK) LTD | — | Sale | 46,696 @ $5.96 | 14,664,939 | Oct 27, 2025 |